Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.13 USD | +3.02% | +9.58% | +63.24% |
May. 15 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
May. 13 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.24% | 1.73B | |
+18.72% | 123B | |
+14.53% | 107B | |
-2.88% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.83% | 16.23B | |
+1.46% | 13.43B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Stifel Adjusts Spyre Therapeutics' Price Target to $54 From $36, Maintains Buy Rating